AMBRA1 and cancer: While treating these cancer cells with a classic autophagy inhibitor 3-methyladenine (3-MA), they found that the cytotoxicity of cisplatin is impaired, which indicates that AMBRA1-mediated autophagy could enhance the cytotoxicity of cisplatin (83).